Latest Breaking News On - Zydus cadilla - Page 1 : vimarsana.com

DelveInsight Business Research, LLP: Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Eli Lilly, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG

Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Eli Lilly, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG

/PRNewswire/ -- DelveInsight's Chronic Lower Back Pain Market Insights report includes a comprehensive understanding of current treatment practices, chronic...

Aflatoxicosis Treatment Market is expected to secure US$ 403.5 Million from 2022 to 2032

Aflatoxicosis Treatment Market is expected to secure US$ 403.5 Million from 2022 to 2032 | FMI

Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

DCGI grants emergency use authorisation to Corbevax for 12-18 year age group

This approval for Corbevax is likely to speed up the ongoing vaccination drive for children between 15 and 18 years of age, and also for those between 12 and 14 years of age. However, the approval is subject to certain conditions.

Dilemma on children's COVID vaccines - Sentinelassam

India not prioritising vaccination for children, for now, is not going to lessen worries of parents of fresh disruption in offline classes if the Omicron variant triggers a spike.

Does India have enough vaccines to deliver Covid-19 booster shots?

The answer is complex, available data shows.

COVID-19 Clinical Trials Market - Forecast(2021

The growth in this industry would be on factors such as a rise in the spending of finding vaccines and other therapeutic drugs.

Omicron threat: How fast is India vaccinating against COVID-19

KT Opinion: Lessons from the Indian vaccination programme

From the standpoint of public health, universal vaccination is as critical against Covid as it is for the continued success of general health programmes